These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22537594)

  • 21. Ineffectiveness of pneumococcal vaccination in cardiovascular prevention: the CAPAMIS study.
    Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; de Diego C; Satue E;
    JAMA Intern Med; 2013 Nov; 173(20):1918-20. PubMed ID: 23712335
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute infections, vaccination and prevention of cardiovascular disease.
    Madjid M
    CMAJ; 2008 Oct; 179(8):749-50. PubMed ID: 18838444
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children ≤ 5 years of age with community-acquired pneumonia.
    Marchese A; Esposito S; Coppo E; Rossi GA; Tozzi A; Romano M; Da Dalt L; Schito GC; Principi N
    Microb Drug Resist; 2011 Sep; 17(3):419-24. PubMed ID: 21510746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved outcomes in community-acquired pneumonia with prior statin use.
    Grau AC; George SM
    Am J Med; 2009 May; 122(5):e15; author reply e17. PubMed ID: 19375535
    [No Abstract]   [Full Text] [Related]  

  • 27. [Child vaccination protects grandparents].
    MMW Fortschr Med; 2005 Dec; 147(51-52):14. PubMed ID: 16404783
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia.
    Feldman C; Normark S; Henriques-Normark B; Anderson R
    J Intern Med; 2019 Jun; 285(6):635-652. PubMed ID: 30584680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention is better than cure: time to change the focus of community-acquired pneumonia management.
    Welte T
    Eur Respir J; 2015 Jun; 45(6):1524-5. PubMed ID: 26028615
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another brick in the wall: adrenomedullin and prognosis in community-acquired pneumonia.
    Krüger S; Frechen D
    Eur Respir J; 2012 May; 39(5):1060-1. PubMed ID: 22547730
    [No Abstract]   [Full Text] [Related]  

  • 32. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children.
    Cheung YB; Zaman SM; Ruopuro ML; Enwere G; Adegbola RA; Greenwood B; Cutts FT
    Trop Med Int Health; 2008 May; 13(5):603-11. PubMed ID: 18331385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual pneumococcal and influenza vaccination: severe concerns about the composition of the control groups.
    Ekkelenkamp MB; Bonten MJ
    Clin Infect Dis; 2011 Feb; 52(4):557-8; author reply 559. PubMed ID: 21258112
    [No Abstract]   [Full Text] [Related]  

  • 34. Pneumococcal vaccination in older adults.
    Marras TK
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Webber C; Patton M; Bonten MJM;
    Vaccine; 2017 Dec; 35(51):7078. PubMed ID: 29195607
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines.
    De Schutter I; Malfroot A; Piérard D; Lauwers S
    Pediatr Pulmonol; 2006 Aug; 41(8):765-70. PubMed ID: 16779850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key developments in paediatrics.
    Bowker R; Stephenson T
    Practitioner; 2005 Jul; 249(1672):481-2, 484-5, 487-8. PubMed ID: 16035496
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower respiratory tract infections: prevention using vaccines.
    Whitney CG; Harper SA
    Infect Dis Clin North Am; 2004 Dec; 18(4):899-917. PubMed ID: 15555831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
    Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
    Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.
    Nelson JC; Jackson M; Yu O; Whitney CG; Bounds L; Bittner R; Zavitkovsky A; Jackson LA
    Vaccine; 2008 Sep; 26(38):4947-54. PubMed ID: 18662735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.